Status:
COMPLETED
Prospective Evaluation of Pain Assessment and Management Protocol for Post-procedural Pain After Endoscopic Mucosal Resection of Colonic Polyps >20mm
Lead Sponsor:
Western Sydney Local Health District
Conditions:
Pain
Endoscopic Mucosal Resection
Eligibility:
All Genders
18+ years
Brief Summary
Endoscopic mucosal resection (EMR) of large (≥20 mm) laterally spreading colonic lesions (LSL) is safe, effective and superior to surgery. This advantage is based on a day stay model of care, however ...
Detailed Description
Large, sessile, colonic polyps of ≥ 20 mm are at increased risk of progressing to colorectal cancer (CRC). Most colonic polyps are small and pedunculated and can be safely removed by conventional poly...
Eligibility Criteria
Inclusion
- All patients referred to Westmead Hospital Endoscopy Unit to undergo an EMR of a colonic lesion reported to be ≥20mm in size.
- Age ≥18 years.
- Patients able to give informed consent to involvement in the trial. For patients who do not speak English, an interpreter will be asked to translate the informed consent.
Exclusion
- Inability to sign informed consent.
Key Trial Info
Start Date :
August 27 2015
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2021
Estimated Enrollment :
325 Patients enrolled
Trial Details
Trial ID
NCT03471156
Start Date
August 27 2015
End Date
September 1 2021
Last Update
June 29 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Westmead Hospital
Westmead, New South Wales, Australia, 2145